ADTX
Aditxt, Inc.
Price Chart
Latest Quote
$0.06
-0.01 (-19.35%)
Current Price
| Previous Close | $0.08 |
| Open | $0.07 |
| Day High | $0.07 |
| Day Low | $0.06 |
| Volume | 29,349,828 |
Stock Information
| Shares Outstanding | 816K |
| Total Debt | $4.23M |
| Cash Equivalents | $269K |
| Revenue | $14K |
| Net Income | $-53.34M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $51K |
| EPS (TTM) | $-1380.80 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.12M |
| Sales | $14K |
| Income | $-53.34M |
| Book/sh | $-861.43 |
| Cash/sh | $0.33 |
| Employees | 26 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.06 |
Returns & Margins
| ROA | -50.76% |
| Gross Margin | 19.89% |
| Operating Margin | -35873.53% |
Ownership
| Insider Ownership | 0.09% |
| Institutional Ownership | 0.22% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.01 |
| P/S | 3.53 |
| P/B | -0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.09 |
| SMA50 | $7.54 |
| SMA200 | $4879.13 |
| ATR | 0.2084 |
| Shares Float | 816K |
| Short Float | 8.77% |
| Short Ratio | 0.02 |
| Rel Volume | 2.23 |
Performance History
| Week | -46.92% |
| Month | -98.30% |
| Quarter | -99.94% |
| 6 Months | -99.99% |
| YTD | -99.97% |
| Year | -100.00% |
| 3 Years | -100.00% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $0.06 | 29,349,828 |
| 2026-06-04 | $0.08 | 28,510,800 |
| 2026-06-03 | $0.09 | 37,922,000 |
| 2026-06-02 | $0.11 | 37,873,800 |
| 2026-06-01 | $0.11 | 32,009,900 |
| 2026-05-29 | $0.12 | 60,244,800 |
| 2026-05-28 | $0.16 | 5,942,100 |
| 2026-05-27 | $0.20 | 5,889,500 |
| 2026-05-26 | $0.25 | 8,839,100 |
| 2026-05-22 | $0.51 | 12,743,400 |
| 2026-05-21 | $1.22 | 316,000 |
| 2026-05-20 | $1.40 | 223,700 |
| 2026-05-19 | $1.52 | 721,000 |
| 2026-05-18 | $1.62 | 411,700 |
| 2026-05-15 | $1.70 | 962,170 |
| 2026-05-14 | $1.81 | 380,785 |
| 2026-05-13 | $2.27 | 118,130 |
| 2026-05-12 | $2.30 | 461,774 |
| 2026-05-11 | $2.94 | 73,011 |
| 2026-05-08 | $3.21 | 69,470 |
| 2026-05-07 | $3.16 | 99,407 |
| 2026-05-06 | $3.64 | 76,667 |
About Aditxt, Inc.
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It develops ADI-100 for skin grafting, psoriasis, and type-1 diabetes. In addition, the company provides Pearsanta that develops molecular tests based on the mitochondrial DNA (mtDNA) to develop tests for early detection of cancer; Mitomic targets mutations in mitochondrial DNA (mtDNA) to detect disease; Mitomic prostate test a blood-based assay that quantifies the level of the 3.4kb mtDNA deletion; and Mitomic endometriosis test, a blood-based assay that quantifies the level of one or more mtDNA deletions. Further, it offers Adivir for commercial development of products to address significant unmet needs in infectious disease and population health; and Adifem address critical unmet needs in women health. The company has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,927 | $627,474 | $756,836 | $766,779 |
| Cost Of Revenue | $2,927 | $627,474 | $756,836 | $766,779 |
| Total Revenue | $3,195 | $133,985 | $645,176 | $933,715 |
| Operating Revenue | $3,195 | $133,985 | $645,176 | $933,715 |
| Expenses | ||||
| Interest Expense | $2,387,853 | $7,363,645 | $6,389,900 | $2,286,086 |
| Total Expenses | $19,573,919 | $27,997,683 | $26,707,601 | $25,869,875 |
| Other Income Expense | $-21,028,645 | $205,831 | $51,712 | $-484,978 |
| Net Non Operating Interest Income Expense | $-2,187,674 | $-7,362,191 | $-6,379,734 | $-2,228,738 |
| Interest Expense Non Operating | $2,387,853 | $7,363,645 | $6,389,900 | $2,286,086 |
| Operating Expense | $19,570,992 | $27,370,209 | $25,950,765 | $25,103,096 |
| Selling And Marketing Expense | $401,996 | $197,863 | $269,284 | $1,849,460 |
| General And Administrative Expense | $15,974,863 | $16,286,216 | $18,607,142 | $15,985,552 |
| Other Non Operating Income Expenses | - | $-208,670 | $51,712 | $58,960 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-41,714,201 | $-34,446,486 | $-32,380,839 | $-27,649,876 |
| Net Interest Income | $-2,187,674 | $-7,362,191 | $-6,379,734 | $-2,228,738 |
| Interest Income | $200,179 | $1,454 | $10,166 | $57,348 |
| Normalized Income | $-20,685,556 | $-34,860,987 | $-32,380,839 | $-27,105,938 |
| Net Income From Continuing And Discontinued Operation | $-41,714,201 | $-34,446,486 | $-32,380,839 | $-27,649,876 |
| Total Operating Income As Reported | $-19,570,724 | $-27,863,698 | $-26,062,425 | $-25,480,098 |
| Net Income Common Stockholders | $-43,101,451 | $-40,353,497 | $-32,700,710 | $-27,687,553 |
| Net Income | $-41,714,201 | $-34,446,486 | $-32,380,839 | $-27,649,876 |
| Net Income Including Noncontrolling Interests | $-42,787,043 | $-35,020,058 | $-32,390,447 | $-27,649,876 |
| Net Income Continuous Operations | $-42,787,043 | $-35,020,058 | $-32,390,447 | $-27,649,876 |
| Pretax Income | $-42,787,043 | $-35,020,058 | $-32,390,447 | $-27,649,876 |
| Special Income Charges | $-23,850,143 | $0 | $0 | $-543,938 |
| Interest Income Non Operating | $200,179 | $1,454 | $10,166 | $57,348 |
| Operating Income | $-19,570,724 | $-27,863,698 | $-26,062,425 | $-24,936,160 |
| Gross Profit | $268 | $-493,489 | $-111,660 | $166,936 |
| Per Share | ||||
| Diluted EPS | $-2828.18 | $-8070699.40 | $-249623.74 | $-2768755.30 |
| Basic EPS | $-2828.18 | $-8070699.40 | $-249623.74 | $-2768755.30 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-19,097,941 | $-27,453,663 | $-25,457,964 | $-24,283,875 |
| Total Unusual Items | $-21,028,645 | $414,501 | $0 | $-543,938 |
| Total Unusual Items Excluding Goodwill | $-21,028,645 | $414,501 | $0 | $-543,938 |
| Reconciled Depreciation | $272,604 | $617,251 | $542,583 | $535,977 |
| EBITDA (Bullshit earnings) | $-40,126,586 | $-27,039,162 | $-25,457,964 | $-24,827,813 |
| EBIT | $-40,399,190 | $-27,656,413 | $-26,000,547 | $-25,363,790 |
| Diluted Average Shares | $15,240 | $5 | $131 | $10 |
| Basic Average Shares | $15,240 | $5 | $131 | $10 |
| Diluted NI Availto Com Stockholders | $-43,101,451 | $-40,353,497 | $-32,700,710 | $-27,687,553 |
| Otherunder Preferred Stock Dividend | $1,387,250 | $5,907,011 | $319,871 | $37,667 |
| Minority Interests | $1,072,842 | $573,572 | $9,608 | $0 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Write Off | $23,766,209 | $0 | $0 | $543,938 |
| Impairment Of Capital Assets | $412,005 | $0 | - | - |
| Restructuring And Mergern Acquisition | $-328,071 | $0 | - | - |
| Gain On Sale Of Security | $2,821,498 | $414,501 | $51,712 | - |
| Research And Development | $3,194,133 | $10,886,130 | $7,074,339 | $7,268,084 |
| Selling General And Administration | $16,376,859 | $16,484,079 | $18,876,426 | $17,835,012 |
| Other Gand A | $15,974,863 | $16,286,216 | $18,607,142 | $15,985,552 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,606,926 | $1,668,465 | $16,046,933 | $5,099,307 |
| Total Assets | $16,516,781 | $32,144,390 | $44,578,327 | $10,735,249 |
| Total Non Current Assets | $12,695,046 | $30,144,549 | $37,665,379 | $5,991,686 |
| Non Current Prepaid Assets | $61,586 | $87,672 | $11,280,182 | $355,366 |
| Non Current Note Receivables | $3,899,859 | $0 | - | - |
| Goodwill And Other Intangible Assets | $2,778 | $6,111 | $9,444 | $107,000 |
| Other Intangible Assets | $2,778 | $6,111 | $9,444 | $107,000 |
| Current Assets | $3,821,735 | $1,999,841 | $6,912,948 | $4,743,563 |
| Prepaid Assets | $617,362 | $3,379 | $217,390 | $496,869 |
| Inventory | $5,774 | $11,245 | $745,502 | $950,093 |
| Receivables | $0 | $1,152,186 | $5,852,954 | $527,961 |
| Accounts Receivable | $0 | $43,435 | $408,326 | $527,961 |
| Cash Cash Equivalents And Short Term Investments | $3,198,599 | $833,031 | $97,102 | $2,768,640 |
| Cash And Cash Equivalents | $3,198,599 | $833,031 | $97,102 | $2,768,640 |
| Cash Financial | $3,198,599 | $833,031 | $97,102 | $2,768,640 |
| Other Receivables | - | $1,108,751 | $5,444,628 | - |
| Allowance For Doubtful Accounts Receivable | - | $-4,000 | $0 | $-18,634 |
| Gross Accounts Receivable | - | $47,435 | $408,326 | $546,595 |
| Non Current Deferred Assets | - | - | $0 | $50,000 |
| Notes Receivable | - | - | - | $0 |
| Other Non Current Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $3,006,528 | $6,920,389 | $18,217,987 | $3,381,859 |
| Long Term Debt And Capital Lease Obligation | $342,904 | $436,354 | $1,041,744 | $1,885,218 |
| Current Debt And Capital Lease Obligation | $2,663,624 | $6,484,035 | $17,176,243 | $1,496,641 |
| Current Debt | $1,855,445 | $5,800,683 | $16,176,300 | $409,983 |
| Net Debt | - | $4,967,652 | $16,079,198 | - |
| Other Current Borrowings | - | $147,823 | $147,823 | $409,983 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,563,099 | $31,052,994 | $28,531,558 | $5,528,942 |
| Total Non Current Liabilities Net Minority Interest | $342,906 | $7,645,871 | $2,641,744 | $1,885,218 |
| Derivative Product Liabilities | $2 | $14,517 | $0 | - |
| Current Liabilities | $12,220,193 | $23,407,123 | $25,889,814 | $3,643,724 |
| Other Current Liabilities | $1,809,716 | $1,354,774 | - | - |
| Current Deferred Liabilities | $53,443 | $106,075 | $158,612 | $188,581 |
| Current Notes Payable | $1,855,445 | $5,652,860 | $16,028,477 | $0 |
| Payables And Accrued Expenses | $7,693,410 | $15,462,239 | $8,554,959 | $1,958,502 |
| Interest Payable | $300,041 | $1,889,527 | $387,692 | - |
| Payables | $7,340,490 | $12,442,373 | $7,523,658 | - |
| Accounts Payable | $7,340,490 | $10,192,373 | $7,523,658 | - |
| Other Payable | - | $2,250,000 | - | - |
| Other Non Current Liabilities | - | - | $1,600,000 | - |
| Equity | ||||
| Common Stock Equity | $5,609,677 | $1,674,548 | $16,056,352 | $5,206,307 |
| Preferred Stock Equity | $27 | $28 | $25 | - |
| Total Equity Gross Minority Interest | $3,953,682 | $1,091,396 | $16,046,769 | $5,206,307 |
| Stockholders Equity | $5,609,704 | $1,674,576 | $16,056,377 | $5,206,307 |
| Gains Losses Not Affecting Retained Earnings | $1,254,170 | $0 | - | - |
| Other Equity Adjustments | $1,254,170 | - | - | - |
| Retained Earnings | $-209,808,770 | $-168,094,569 | $-127,741,072 | $-95,040,362 |
| Preferred Securities Outside Stock Equity | $0 | $7,195,000 | - | - |
| Long Term Equity Investment | $6,646,056 | $27,277,211 | $22,277,211 | $0 |
| Other | ||||
| Treasury Shares Number | $0 | $1 | $0 | $0 |
| Ordinary Shares Number | $15,240 | $5 | $0 | $10 |
| Share Issued | $15,240 | $5 | $131 | $10 |
| Tangible Book Value | $5,606,899 | $1,668,437 | $16,046,908 | $5,099,307 |
| Invested Capital | $7,465,122 | $7,475,231 | $32,232,652 | $5,616,290 |
| Working Capital | $-8,398,458 | $-21,407,282 | $-18,976,866 | $1,099,839 |
| Capital Lease Obligations | $1,151,083 | $1,119,706 | $2,041,687 | $2,971,876 |
| Total Capitalization | $5,609,704 | $1,674,576 | $16,056,377 | $5,206,307 |
| Minority Interest | $-1,656,022 | $-583,180 | $-9,608 | $0 |
| Treasury Stock | $201,605 | $201,605 | $201,605 | $201,605 |
| Additional Paid In Capital | $214,365,470 | $169,970,721 | $143,999,018 | $100,448,166 |
| Capital Stock | $439 | $29 | $36 | $108 |
| Common Stock | $412 | $1 | $11 | $108 |
| Preferred Stock | $27 | $28 | $25 | $0 |
| Long Term Capital Lease Obligation | $342,904 | $436,354 | $1,041,744 | $1,885,218 |
| Current Capital Lease Obligation | $808,179 | $683,352 | $999,943 | $1,086,658 |
| Current Accrued Expenses | $352,920 | $3,019,866 | $1,031,301 | - |
| Investments And Advances | $6,646,056 | $27,277,211 | $22,277,211 | $0 |
| Investmentsin Subsidiariesat Cost | $6,646,056 | $27,277,211 | $22,277,211 | $0 |
| Net PPE | $2,084,767 | $2,773,555 | $4,098,542 | $5,479,320 |
| Accumulated Depreciation | $-2,112,000 | $-1,842,728 | $-1,251,015 | $-815,987 |
| Gross PPE | $4,196,767 | $4,616,283 | $5,349,557 | $6,295,307 |
| Leases | $120,440 | $120,440 | $120,440 | $120,440 |
| Other Properties | $3,638,514 | $4,060,707 | $4,793,981 | $2,581,325 |
| Machinery Furniture Equipment | $437,813 | $435,136 | $435,136 | $433,085 |
| Properties | $0 | $0 | $0 | $0 |
| Buildings And Improvements | - | - | $2,200,299 | $3,160,457 |
| Raw Materials | - | - | - | $950,093 |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-25,702,102 | $-16,762,121 | $-19,218,074 | $-22,759,085 |
| Operating Activities | ||||
| Operating Cash Flow | $-25,688,359 | $-16,762,121 | $-19,203,667 | $-22,392,006 |
| Cash Flow From Continuing Operating Activities | $-25,688,359 | $-16,762,121 | $-19,203,667 | $-22,392,006 |
| Operating Gains Losses | $-2,821,498 | $-411,501 | - | $6,976 |
| Investing Activities | ||||
| Capital Expenditure | $-13,743 | - | $-14,407 | $-367,079 |
| Investing Cash Flow | $-2,438,743 | $-5,000,000 | $-14,407 | $-241,918 |
| Cash Flow From Continuing Investing Activities | $-2,438,743 | $-5,000,000 | $-14,407 | $-241,918 |
| Net Other Investing Changes | $-2,425,000 | - | - | $125,161 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-9,206,442 | $-2,851,871 | $-1,000 | $-20,000 |
| Issuance Of Capital Stock | $44,128,225 | $21,166,343 | $11,055,883 | $17,253,307 |
| Financing Cash Flow | $30,492,670 | $22,498,050 | $16,546,536 | $17,530,503 |
| Cash Flow From Continuing Financing Activities | $30,492,670 | $22,498,050 | $16,546,536 | $17,530,503 |
| Net Other Financing Charges | $1,108,751 | $4,335,877 | $-261,160 | $-400,491 |
| Net Preferred Stock Issuance | $-9,206,442 | $-2,851,871 | $0 | $0 |
| Net Common Stock Issuance | $44,128,225 | $21,166,343 | $11,054,883 | $17,233,307 |
| Common Stock Issuance | $44,128,225 | $21,166,343 | $11,054,883 | $17,233,307 |
| Preferred Stock Issuance | - | $0 | $1,000 | $20,000 |
| Other | ||||
| Repayment Of Debt | $-7,406,882 | $-6,014,942 | $-3,840,011 | $-3,286,887 |
| Issuance Of Debt | $1,869,018 | $4,616,153 | $9,592,824 | $2,875,000 |
| Interest Paid Supplemental Data | $2,465,546 | $1,235,640 | $3,070,620 | $753,038 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $3,198,599 | $833,031 | $97,102 | $2,768,640 |
| Beginning Cash Position | $833,031 | $97,102 | $2,768,640 | $7,872,061 |
| Changes In Cash | $2,365,568 | $735,929 | $-2,671,538 | $-5,103,421 |
| Proceeds From Stock Option Exercised | $0 | $1,246,490 | $0 | $1,109,574 |
| Preferred Stock Payments | $-9,206,442 | $-2,851,871 | $-1,000 | $-20,000 |
| Net Issuance Payments Of Debt | $-5,537,864 | $-1,398,789 | $5,752,813 | $-411,887 |
| Net Short Term Debt Issuance | $-5,537,864 | $-1,398,789 | $5,752,813 | $-411,887 |
| Short Term Debt Payments | $-7,406,882 | $-6,014,942 | $-3,840,011 | $-3,286,887 |
| Short Term Debt Issuance | $1,869,018 | $4,616,153 | $9,592,824 | $2,875,000 |
| Net Investment Purchase And Sale | $0 | $-5,000,000 | $0 | - |
| Purchase Of Investment | $0 | $-5,000,000 | $0 | - |
| Net PPE Purchase And Sale | $-13,743 | $0 | $-14,407 | $-367,079 |
| Purchase Of PPE | $-13,743 | $0 | $-14,407 | $-367,079 |
| Change In Working Capital | $-6,171,884 | $7,093,988 | $9,099,118 | $-493,437 |
| Change In Other Current Liabilities | $0 | $667,000 | $1,600,000 | $0 |
| Change In Payables And Accrued Expense | $-5,632,893 | $5,095,091 | $6,646,457 | $412,959 |
| Change In Prepaid Assets | $-587,897 | $232,749 | $528,435 | $-12,883 |
| Change In Inventory | $5,471 | $734,257 | $204,591 | $-455,396 |
| Change In Receivables | $43,435 | $364,891 | $119,635 | $-438,117 |
| Changes In Account Receivables | $43,435 | $364,891 | $119,635 | $-438,117 |
| Other Non Cash Items | $1,157,937 | $4,212,465 | $2,143,061 | $1,533,048 |
| Stock Based Compensation | $483,311 | $6,745,734 | $1,402,018 | $3,131,368 |
| Asset Impairment Charge | $24,178,214 | $0 | $0 | $543,938 |
| Depreciation Amortization Depletion | $272,604 | $617,251 | $542,583 | $535,977 |
| Depreciation And Amortization | $272,604 | $617,251 | $542,583 | $535,977 |
| Amortization Cash Flow | $3,333 | $3,333 | $107,556 | $107,000 |
| Amortization Of Intangibles | $3,333 | $3,333 | $107,556 | $107,000 |
| Depreciation | $269,271 | $613,918 | $435,027 | $428,977 |
| Gain Loss On Investment Securities | $-2,821,498 | $-414,501 | - | - |
| Gain Loss On Sale Of PPE | $0 | $3,000 | $0 | $6,976 |
| Net Income From Continuing Operations | $-42,787,043 | $-35,020,058 | $-32,390,447 | $-27,649,876 |
| Net Long Term Debt Issuance | - | - | - | $-812,378 |
| Long Term Debt Payments | - | - | - | $-3,687,378 |
| Long Term Debt Issuance | - | - | - | $2,875,000 |
Fetched: 2026-06-02